Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Mundisugih, J., Ravindran, D
Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis: from pathophysiology to clinical practice
Yes, clinical evidence supports continuous semaglutide use for 23 years or longer when medically appropriate
Because PLGA-based nanoparticles have the potential to move from proof of concept and become a transformative solution in PD therapeutics, novel strategies to overcome their limitations are warranted
US$ 23.00
US$ 26.60
US$ 20.07
US$ 20.06
US$ 28.79
